These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 8736724)
41. Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. Sivin I; Díaz S; Croxatto HB; Miranda P; Shaaban M; Sayed EH; Xiao B; Wu SC; Du M; Alvarez F; Brache V; Basnayake S; McCarthy T; Lacarra M; Mishell DR; Koetsawang S; Stern J; Jackanicz T Contraception; 1997 Apr; 55(4):225-32. PubMed ID: 9179454 [TBL] [Abstract][Full Text] [Related]
42. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant. Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133 [TBL] [Abstract][Full Text] [Related]
43. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics. Belsey EM; d'Arcangues C; Carlson N Contraception; 1988 Aug; 38(2):243-57. PubMed ID: 2971508 [TBL] [Abstract][Full Text] [Related]
44. Recent experience with and future directions of contraceptive implants and injectable contraceptives. Alvarez-Sanchez F; Brache V; Faundes A Curr Opin Obstet Gynecol; 1993 Dec; 5(6):805-14. PubMed ID: 8286694 [TBL] [Abstract][Full Text] [Related]
46. [Historical survey of modern reversible contraceptive methods]. Mbabajende V Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230 [TBL] [Abstract][Full Text] [Related]
47. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects. Laurikka-Routti M; Haukkamaa M Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263 [TBL] [Abstract][Full Text] [Related]
48. NORPLANT contraceptive implants advancing. Segal SJ Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797 [TBL] [Abstract][Full Text] [Related]
49. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability. Coukell AJ; Balfour JA Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600 [TBL] [Abstract][Full Text] [Related]
50. Clinical relevance in present day hormonal contraception. Regidor PA Horm Mol Biol Clin Investig; 2018 Oct; 37(1):. PubMed ID: 30367791 [TBL] [Abstract][Full Text] [Related]
51. [New advances in contraception and sterilization]. Iglesias Cortit L Med Clin (Barc); 1985 Nov; 85(14):588-95. PubMed ID: 3908850 [TBL] [Abstract][Full Text] [Related]
52. Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia. Simmons R; Fajans P; Lubis F Contraception; 1994 May; 49(5):509-25. PubMed ID: 8045135 [TBL] [Abstract][Full Text] [Related]
53. Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women. Landgren BM; Hall PE; Cekan SZ Contraception; 1992 Apr; 45(4):343-9. PubMed ID: 1516366 [TBL] [Abstract][Full Text] [Related]